Fluoxetine’s Effects on Obesity, Diabetes Biomarkers
In a groundbreaking systematic review and meta-analysis recently published in BMC Psychiatry, researchers have unveiled compelling evidence supporting the role ...
In a groundbreaking systematic review and meta-analysis recently published in BMC Psychiatry, researchers have unveiled compelling evidence supporting the role ...
In a groundbreaking advance at the intersection of renewable materials and metabolic disease management, researchers have unveiled a novel therapeutic ...
The growing prevalence of type 2 diabetes has led researchers to explore diverse treatment options beyond conventional medications. In a ...
Recent research has highlighted the potential of a traditional Chinese medicinal herb, Atractylodes lancea, in addressing critical health issues arising ...
In a groundbreaking development within the field of geriatric medicine, researchers have unveiled the SUGAR handshake intervention, a novel approach ...
In a groundbreaking development for the treatment of obesity, recent phase 3 clinical trials have demonstrated that a significantly higher ...
In the landscape of modern medicine, obesity remains one of the most formidable public health challenges, associated intricately with a ...
In recent years, the prevalence of type 2 diabetes has skyrocketed, posing significant challenges to healthcare systems worldwide. One of ...
In an era increasingly characterized by escalating rates of diabetes and related complications, the emergence of innovative pharmacological therapies has ...
In a groundbreaking study published in the esteemed journal Diabetes Therapy, researchers have examined the effects of empagliflozin, a drug ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine